BENEFICIAL EFFECTS ON ALBUMINURIA IN EXPERIMENTAL DIABETES WITH ALT 946, A NOVEL INHIBITOR OF ADVANCED GLYCATION

Nephrology ◽  
2000 ◽  
Vol 5 (3) ◽  
pp. A99-A99
Author(s):  
Forbes Jm ◽  
Soulis T ◽  
Thallas V ◽  
Panagiotopoulos S ◽  
Jerums G.
2000 ◽  
Vol 50 ◽  
pp. 356
Author(s):  
J.M Forbes ◽  
T Soulis ◽  
V Thallas ◽  
D Long ◽  
S Panagiotopoulos ◽  
...  

2016 ◽  
Vol 83 ◽  
pp. 162-168 ◽  
Author(s):  
Gabriela Câmara Vicente ◽  
André Manoel Correia-Santos ◽  
Akemi Suzuki ◽  
Juliana Saraiva dos Anjos ◽  
Luis Guillermo Coca Velarde ◽  
...  

2019 ◽  
Vol 25 (5-6) ◽  
pp. 303-308
Author(s):  
A. A Spasov ◽  
Yulia A. Govorova ◽  
L. V Naumehko ◽  
D. A Babkov ◽  
A. S Taran ◽  
...  

Nonenzymatic glycosylation of lens proteins in diabetes mellitus is one of the pathogenetic mechanisms of cataract formation. According to the results of this study, aminoguanidine, which has anti-glycation activity, inhibits cataractogenesis in experimental diabetes. Laboratory animals with streptozotocin-induced diabetes mellitus treated with aminoguanidine showed less clouding in the lenses, and the content of advanced glycation end products, in particular, carboxymethyllysine, in the lenses was found to be reduced compared to the same parameters in animals from the control diabetic group.


2004 ◽  
Vol 311 (2) ◽  
pp. 456-466 ◽  
Author(s):  
Merlin C. Thomas ◽  
Christos Tikellis ◽  
Phillip Kantharidis ◽  
Wendy C. Burns ◽  
Mark E. Cooper ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document